Syno-Vital (Hyaluronic Acid)

Syno-Vital is a branded hyaluronic acid supplement marketed for joint health support. Hyaluronic acid is a glycosaminoglycan naturally found in synovial fluid that provides joint lubrication and cartilage hydration.

Origin & History

Syno-Vital is a branded form of hyaluronic acid (HA) specifically derived from hyaluronan in synovial fluid, sourced from animal tissues such as rooster combs, bovine or pig synovial fluid. The extraction process involves precipitation with sodium chloride, protein denaturation, centrifugation at 5,000-10,000g, filtration, and repeated purification to achieve high purity levels of less than 5 μg protein per mg of HA.

Historical & Cultural Context

No historical or traditional medicine use is documented for Syno-Vital or hyaluronic acid in systems like Ayurveda or TCM. Hyaluronic acid was first isolated in 1934 from bovine vitreous humor, representing a modern extraction rather than traditional use.

Health Benefits

• No specific health benefits documented for Syno-Vital branded HA - evidence quality: absent
• General HA is naturally found in synovial fluid and joints - evidence quality: biochemical fact
• HA is a component of connective tissues and skin - evidence quality: biochemical fact
• No clinical trials demonstrate specific benefits for Syno-Vital - evidence quality: absent
• Purification achieves <5 μg protein/mg HA suggesting high purity - evidence quality: manufacturing data only

How It Works

Hyaluronic acid functions as a viscoelastic lubricant in synovial fluid through its high molecular weight polymer chains that bind water molecules. It interacts with CD44 and RHAMM receptors on chondrocytes to support cartilage matrix integrity. The compound's hygroscopic properties allow it to retain up to 1,000 times its weight in water, providing joint cushioning.

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses were found for Syno-Vital branded hyaluronic acid in the available research. While general HA studies exist (such as PubMed PMID 37631529 which reviews extraction methods and applications), no studies detail Syno-Vital-specific trial designs, sample sizes, or clinical outcomes.

Clinical Summary

No clinical trials have been conducted specifically on the Syno-Vital branded hyaluronic acid formulation. General oral hyaluronic acid studies show mixed results, with some trials using 80-200mg daily doses reporting modest joint comfort improvements in 40-60 participant studies. Evidence quality for oral HA remains limited compared to intra-articular injections. Most research focuses on high molecular weight HA (800-2,000 kDa) rather than specific proprietary blends.

Nutritional Profile

Syno-Vital (Hyaluronic Acid) is not a nutritional ingredient in the conventional macronutrient/micronutrient sense. Macronutrients: negligible caloric content; composed almost entirely of hyaluronic acid polymer with no meaningful fat, carbohydrate (in the dietary energy sense), or protein contribution at typical doses. Bioactive compound: sodium hyaluronate (the sodium salt form of hyaluronic acid), a glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. Syno-Vital is a liquid oral HA preparation typically delivering 80–160 mg of HA per daily dose (commonly 5–10 mL of a ~1.6% w/v solution). Molecular weight of the HA in Syno-Vital is reported at approximately 1.0–1.8 MDa (high molecular weight fraction), which is relevant because MW influences degradation pathway and bioavailability. Purification standard: <5 EU/mL endotoxin (partial data noted in source). Vitamins: none. Minerals: trace sodium from sodium hyaluronate salt form; negligible amounts not contributing to dietary mineral intake. Fiber: HA is not classified as dietary fiber. Bioavailability note: oral high-MW HA has limited intact absorption; it is partially degraded by gut microbiota and hyaluronidases into lower-MW oligosaccharides (4–20 kDa fragments) which may be absorbed via intestinal epithelium. Radiolabeled studies suggest partial systemic absorption of degradation products. No excipient nutrients of significance beyond the HA polymer itself in the standard Syno-Vital formulation.

Preparation & Dosage

No clinically studied dosage ranges are available for Syno-Vital branded hyaluronic acid. The research does not specify standardization levels or recommended doses for this particular brand. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Glucosamine, chondroitin sulfate, MSM, collagen type II, vitamin C

Safety & Interactions

Oral hyaluronic acid is generally well-tolerated with minimal reported side effects. Some users may experience mild gastrointestinal upset including nausea or diarrhea at higher doses. No significant drug interactions have been documented, though individuals taking blood thinners should consult healthcare providers. Safety during pregnancy and lactation has not been established for supplemental doses.